Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.
- Published In:
- Frontiers in neuroscience, 15, 621996 (2021)
- Authors:
- Minakawa, Eiko N, Nagai, Yoshitaka
- Database ID:
- RPEP-05613
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05613APA
Minakawa, Eiko N; Nagai, Yoshitaka. (2021). Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.. Frontiers in neuroscience, 15, 621996. https://doi.org/10.3389/fnins.2021.621996
MLA
Minakawa, Eiko N, et al. "Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases.." Frontiers in neuroscience, 2021. https://doi.org/10.3389/fnins.2021.621996
RethinkPeptides
RethinkPeptides Research Database. "Protein Aggregation Inhibitors as Disease-Modifying Therapie..." RPEP-05613. Retrieved from https://rethinkpeptides.com/research/minakawa-2021-protein-aggregation-inhibitors-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.